Intelligence / Healthtech / FDA 510(k) Clearances / Bayer Medical Care, Inc.
Bayer Medical Care, Inc.
6 Oct 2026: Device cleared · MEDRAD® MRXperion MR Injection System and MR Injection System Syringe Kit; MEDRAD® IS12 Module (IS12); MEDRAD® Imaging Bulk Package Transfer Spike. Recorded in the openFDA device 510(k) data.
- Decided
- 6 Oct 2026
- Device
- MEDRAD® MRXperion MR Injection System and MR Injection System Syringe Kit; MEDRAD® IS12 Module (IS12); MEDRAD® Imaging Bulk Package Transfer Spike
- Specialty
- Cardiovascular
- Country
- United States
- Location
- Indianola, PA
- Clearance type
- Traditional
- 510(k) number
- K262043
- Submitted
- 2026-06-17
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Find the decision makers at Bayer Medical Care, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Bayer Medical Care, Inc. in our registers.
More in Cardiovascular
FDA 510(k) Clearances
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.